Mustafa Suker
Overview
Explore the profile of Mustafa Suker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doppenberg D, van Dam J, Han Y, Bonsing B, Busch O, Festen S, et al.
Br J Surg
. 2023 Jul;
110(10):1374-1380.
PMID: 37440421
Background: Guidelines suggest that the serum carbohydrate antigen (CA19-9) level should be used when deciding on neoadjuvant treatment in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (hereafter referred...
2.
van Dongen J, Versteijne E, Bonsing B, Mieog J, de Hingh I, Festen S, et al.
Eur J Surg Oncol
. 2022 Dec;
49(4):811-817.
PMID: 36585300
Background: The necessity of the staging laparoscopy in patients with pancreatic cancer is still debated. The objective of this study was to assess the yield of staging laparoscopy for detecting...
3.
Aziz M, van Dongen J, Saida L, Suker M, van Vugt J, van Putten Y, et al.
Front Oncol
. 2022 Mar;
12:827755.
PMID: 35296013
Background And Aims: Failing immune surveillance in pancreatic ductal adenocarcinoma (PDAC) is related to poor prognosis. PDAC is also characterized by its substantial alterations to patients' body composition. Therefore, we...
4.
Versteijne E, van Dam J, Suker M, Janssen Q, Groothuis K, Akkermans-Vogelaar J, et al.
J Clin Oncol
. 2022 Jan;
40(11):1220-1230.
PMID: 35084987
Purpose: The benefit of neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic cancer remains controversial. Initial results of the PREOPANC trial failed to demonstrate a statistically significant overall survival (OS)...
5.
Vietsch E, Peran I, Suker M, van den Bosch T, van der Sijde F, Kros J, et al.
Appl Sci (Basel)
. 2021 Sep;
9(22).
PMID: 34484811
Clinical follow-up aided by changes in the expression of circulating microRNAs (miRs) may improve prognostication of pancreatic ductal adenocarcinoma (PDAC) patients. Changes in 179 circulating miRs due to cancer progression...
6.
Strijker M, van der Sijde F, Suker M, Boermeester M, Bonsing B, Bruno M, et al.
HPB (Oxford)
. 2021 Jun;
23(12):1886-1896.
PMID: 34103247
Background: We evaluated the stroma marker A Disintegrin And Metalloprotease 12 (ADAM12) as a preoperative prognostic and treatment-predictive marker for overall survival (OS) in pancreatic ductal adenocarcinoma (PDAC) and periampullary...
7.
Versteijne E, Suker M, Groen J, Besselink M, Bonsing B, Bosscha K, et al.
Ann Surg
. 2020 Dec;
275(5):972-978.
PMID: 33273349
Objectives: To investigate the accrual proportion and patients' reasons for not participating in the PREOPANC trial on neoadjuvant chemoradiotherapy versus immediate surgery in resectable and borderline resectable pancreatic cancer, and...
8.
van Dongen J, Suker M, Versteijne E, Bonsing B, Mieog J, de Vos-Geelen J, et al.
Ann Surg
. 2020 Nov;
275(5):979-984.
PMID: 33201120
Objectives: To investigate the effect of preoperative chemoradiotherapy on surgical complications in patients after pancreatic resection for (borderline-)resectable pancreatic cancer. Summary Of Background Data: Preoperative chemoradiotherapy is increasingly used in...
9.
Mackay T, van Rijssen L, Andriessen J, Suker M, Creemers G, Eskens F, et al.
J Natl Compr Canc Netw
. 2020 Jun;
18(6):704-711.
PMID: 32502981
Background: This study sought to assess patient satisfaction and quality of life (QoL) before and after treatment of pancreatic and periampullary cancer. Methods: We conducted a prospective multicenter study of...
10.
Suker M, Groot Koerkamp B, Nuyttens J, Dwarkasing R, Homs M, Eskens F, et al.
J Surg Oncol
. 2020 May;
122(3):450-456.
PMID: 32378193
Objective: To evaluate the incidence of pulmonary metastases on chest computed tomography (CT) in patients with locally advanced pancreatic cancer (LAPC). Methods: All patients diagnosed with LAPC in a single...